Cargando…

Structural Requirements of N-alpha-Mercaptoacetyl Dipeptide (NAMdP) Inhibitors of Pseudomonas Aeruginosa Virulence Factor LasB: 3D-QSAR, Molecular Docking, and Interaction Fingerprint Studies

The zinc metallopeptidase Pseudomonas elastase (LasB) is a virulence factor of Pseudomonas aeruginosa (P. aeruginosa), a pathogenic bacterium that can cause nosocomial infections. The present study relates the structural analysis of 118 N-alpha-mercaptoacetyl dipeptides (NAMdPs) as LasB inhibitors....

Descripción completa

Detalles Bibliográficos
Autores principales:	Velázquez-Libera, José Luis, Murillo-López, Juliana Andrea, F. de la Torre, Alexander, Caballero, Julio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940830/ https://www.ncbi.nlm.nih.gov/pubmed/31817391 http://dx.doi.org/10.3390/ijms20246133

Ejemplares similares

Insights into the Structural Requirements of 2(S)-Amino-6-Boronohexanoic Acid Derivatives as Arginase I Inhibitors: 3D-QSAR, Docking, and Interaction Fingerprint Studies
por: Velázquez-Libera, José Luis, et al.
Publicado: (2018)

The Pseudomonas aeruginosa protease LasB directly activates IL-1β
por: Sun, Josh, et al.
Publicado: (2020)

Design of a gold nanoprobe for the detection of Pseudomonas aeruginosa elastase gene (lasB)
por: Farhangi, Alireza, et al.
Publicado: (2020)

Human Single-Chain Antibodies That Neutralize Elastolytic Activity of Pseudomonas aeruginosa LasB
por: Santajit, Sirijan, et al.
Publicado: (2021)

The Structures and Binding Modes of Small-Molecule Inhibitors of Pseudomonas aeruginosa Elastase LasB
por: Camberlein, Virgyl, et al.
Publicado: (2022)

Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33
por: Velázquez-Libera, José Luis, et al.
Publicado: (2019)

Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models
por: Everett, Martin J., et al.
Publicado: (2023)

Clinical Strains of Pseudomonas aeruginosa Secrete LasB Elastase to Induce Hemorrhagic Diffuse Alveolar Damage in Mice
por: Zhu, Yajie, et al.
Publicado: (2021)

Structure-Based Design of α-Substituted Mercaptoacetamides as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa
por: Kaya, Cansu, et al.
Publicado: (2022)

Effect of Satureja khuzistanica essential oil (SKEO) extract on expression of lasA and lasB genes in Pseudomonas aeruginosa
por: Islamieh, Davoud Iman, et al.
Publicado: (2019)

Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients
por: Llanos, Agustina, et al.
Publicado: (2023)

3D-QSAR, Molecular Docking and Molecular Dynamics Simulation of Pseudomonas aeruginosa LpxC Inhibitors
por: Zuo, Ke, et al.
Publicado: (2017)

Enzymatic Depilation of Animal Hide: Identification of Elastase (LasB) from Pseudomonas aeruginosa MCM B-327 as a Depilating Protease
por: Pandeeti, Emmanuel Vijay Paul, et al.
Publicado: (2011)

VE-Cadherin Cleavage by LasB Protease from Pseudomonas aeruginosa Facilitates Type III Secretion System Toxicity in Endothelial Cells
por: Golovkine, Guillaume, et al.
Publicado: (2014)

N-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from Pseudomonas aeruginosa
por: Yahiaoui, Samir, et al.
Publicado: (2021)

Disarming Pseudomonas aeruginosa Virulence by the Inhibitory Action of 1,10-Phenanthroline-5,6-Dione-Based Compounds: Elastase B (LasB) as a Chemotherapeutic Target
por: Galdino, Anna Clara M., et al.
Publicado: (2019)

Characterization of Putative Virulence Factors of Pseudomonas aeruginosa Strain RBS Isolated from a Saltern, Tunisia: Effect of Metal Ion Cofactors on the Structure and the Activity of LasB
por: Rigane, E., et al.
Publicado: (2020)

Pseudomonas aeruginosa LasB Subverts Alveolar Macrophage Activity by Interfering With Bacterial Killing Through Downregulation of Innate Immune Defense, Reactive Oxygen Species Generation, and Complement Activation
por: Bastaert, Fabien, et al.
Publicado: (2018)

Gaussian Accelerated Molecular Dynamics in NAMD
por: Pang, Yui Tik, et al.
Publicado: (2016)

Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway
por: Saint-Criq, Vinciane, et al.
Publicado: (2018)

The Basis for Natural Multiresistance to Phage in Pseudomonas aeruginosa
por: Pourcel, Christine, et al.
Publicado: (2020)

QSAR Analysis of 2-Amino or 2-Methyl-1-Substituted Benzimidazoles Against Pseudomonas aeruginosa
por: Podunavac-Kuzmanović, Sanja O., et al.
Publicado: (2009)

QSAR Models for Active Substances against Pseudomonas aeruginosa Using Disk-Diffusion Test Data
por: Bugeac, Cosmin Alexandru, et al.
Publicado: (2021)

A new two-strip TLC method for the quality control of technetium-99m mercaptoacetyl-triglycine ((99m)Tc-MAG3)
por: Straub, Marietta, et al.
Publicado: (2018)

QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate
por: Edache, Emmanuel Israel, et al.
Publicado: (2022)

Substrate‐Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors
por: Kaya, Cansu, et al.
Publicado: (2021)

Towards Intelligent Drug Design System: Application of Artificial Dipeptide Receptor Library in QSAR-Oriented Studies
por: Bak, Andrzej, et al.
Publicado: (2018)

Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA
por: Mena-Ulecia, Karel, et al.
Publicado: (2015)

NAMD goes quantum: An integrative suite for QM/MM simulations
por: Melo, Marcelo C. R., et al.
Publicado: (2018)

Insights into the Interactions between Maleimide Derivates and GSK3β Combining Molecular Docking and QSAR
por: Quesada-Romero, Luisa, et al.
Publicado: (2014)

Topological pharmacophores: pros & cons of QSARs based on 2D pharmacophore fingerprints
por: Horvath, D
Publicado: (2008)

QSAR-derived affinity fingerprints (part 2): modeling performance for potency prediction
por: Cortés-Ciriano, Isidro, et al.
Publicado: (2020)

Communicating with patients with nAMD and their families during the COVID-19 pandemic
por: Korobelnik, Jean-François, et al.
Publicado: (2020)

Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME
por: Avery, Robert L., et al.
Publicado: (2023)

Quinazoline analogues as cytotoxic agents; QSAR, docking, and in silico studies
por: Emami, Leila, et al.
Publicado: (2021)

Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking
por: Castillo-Campos, Luis, et al.
Publicado: (2023)

Infectious Endocarditis by Pseudomonas aeruginosa in an Immunocompetent Adult
por: Yglesias Dimadi, Ioanna I, et al.
Publicado: (2023)

QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping
por: Škuta, C., et al.
Publicado: (2020)

New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
por: Patel, Prem, et al.
Publicado: (2021)

A model to quantify the influence of treatment patterns and optimize outcomes in nAMD
por: Ziemssen, Focke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n44lp8otpbq8b2k8ctm3cfb9u6